Jim Simons Madrigal Pharmaceuticals, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q3 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 120,682 shares of MDGL stock, worth $63.9 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

120,682

Previous 10,836 1013.71%

Holding current value

$63.9 Million

Previous $3.28 Million 1588.08%

% of portfolio

0.08%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$287.52 - $458.66 $31.6 Million - $50.4 Million	109,846 Added 1013.71%	120,682 $55.4 Million
Q2 2025 Aug 13, 2025	SELL	$267.56 - $340.8 $19.9 Million - $25.3 Million	-74,250 Reduced 87.26%	10,836 $3.28 Million
Q1 2025 May 14, 2025	SELL	$272.79 - $355.88 $20.6 Million - $26.9 Million	-75,696 Reduced 47.08%	85,086 $28.2 Million
Q4 2024 Feb 13, 2025	BUY	$202.45 - $354.85 $23.5 Million - $41.3 Million	116,285 Added 261.33%	160,782 $49.6 Million
Q3 2024 Nov 13, 2024	BUY	$212.22 - $292.96 $9.44 Million - $13 Million	44,497 New	44,497 $9.44 Million
Q3 2023 Nov 14, 2023	SELL	$146.04 - $225.78 $1.55 Million - $2.39 Million	-10,600 Reduced 13.47%	68,082 $9.94 Million
Q2 2023 Aug 11, 2023	SELL	$203.88 - $312.0 $19.7 Million - $30.2 Million	-96,700 Reduced 55.14%	78,682 $18.2 Million
Q1 2023 May 12, 2023	BUY	$231.06 - $307.08 $39.5 Million - $52.4 Million	170,800 Added 3727.63%	175,382 $42.5 Million
Q4 2022 Feb 13, 2023	BUY	$58.39 - $296.54 $267,542 - $1.36 Million	4,582 New	4,582 $1.33 Million
Q2 2022 Aug 12, 2022	SELL	$58.04 - $100.2 $278,592 - $480,960	-4,800 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$55.89 - $101.89 $134,136 - $244,536	2,400 Added 100.0%	4,800 $471,000
Q4 2021 Feb 11, 2022	SELL	$72.34 - $95.09 $1.06 Million - $1.4 Million	-14,711 Reduced 85.97%	2,400 $203,000
Q3 2021 Nov 12, 2021	SELL	$78.35 - $105.02 $2.81 Million - $3.77 Million	-35,871 Reduced 67.7%	17,111 $1.37 Million
Q2 2021 Aug 13, 2021	BUY	$97.2 - $137.59 $1.82 Million - $2.57 Million	18,700 Added 54.55%	52,982 $5.16 Million
Q1 2021 May 13, 2021	BUY	$108.54 - $125.2 $27,026 - $31,174	249 Added 0.73%	34,282 $4.01 Million
Q4 2020 Feb 10, 2021	BUY	$110.06 - $133.7 $1.35 Million - $1.64 Million	12,251 Added 56.24%	34,033 $3.78 Million
Q3 2020 Nov 13, 2020	SELL	$99.78 - $124.21 $5.05 Million - $6.29 Million	-50,600 Reduced 69.91%	21,782 $2.59 Million
Q2 2020 Aug 13, 2020	BUY	$60.13 - $125.71 $2.76 Million - $5.77 Million	45,900 Added 173.33%	72,382 $8.2 Million
Q1 2020 May 14, 2020	BUY	$66.76 - $93.49 $1.77 Million - $2.48 Million	26,482 New	26,482 $1.77 Million

Others Institutions Holding MDGL

# of Institutions

391

Shares Held

23.2M

Call Options Held

654K

Put Options Held

490K

View Full List

About MADRIGAL PHARMACEUTICALS, INC.

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $9.05B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

More about MDGL

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account